| 前收市價 | 209.40 |
| 開市 | 211.70 |
| 買盤 | 210.60 x 120000 |
| 賣出價 | 211.80 x 120000 |
| 今日波幅 | 211.70 - 211.70 |
| 52 週波幅 | 148.35 - 213.50 |
| 成交量 | |
| 平均成交量 | 19 |
| 市值 | 無 |
| Beta 值 (5 年，每月) | 無 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | 無 |
| 業績公佈日 | 2024年7月30日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
ZacksAvanos (AVNS) Q1 Earnings & Revenues Surpass Estimates
Avanos' (AVNS) first-quarter results show strong bottom-line improvement along with decent growth in segmental revenues.
ZacksSurmodics (SRDX) Q2 Earnings Top Estimates, '24 View Up
Surmodics (SRDX) fiscal second-quarter results showcase growth in the medical device segment. The bottom line improves and beats the Zacks Consensus Estimate.
ZacksGE Healthcare's (GEHC) Revolution RT to Aid Cancer Treatment
GE Healthcare (GEHC) unveils Revolution RT, along with other upgrades, from its portfolio during the ESTRO 2024 Congress.
